TP53 and colorectal carcinoma: By contrast, half of the patients with left-sided CRC and TP53 mutations experienced tumor recurrence, even though a minimum of half did not show colonization by CoPEC (50% pks−, 37.5% pks+ and 12.5% not analyzed, Supplementary Figure S3B).